Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACET |
---|---|---|
09:32 ET | 5258 | 1.51 |
09:34 ET | 600 | 1.52 |
09:36 ET | 755 | 1.515 |
09:38 ET | 4026 | 1.51 |
09:39 ET | 200 | 1.505 |
09:41 ET | 1000 | 1.505 |
09:43 ET | 1100 | 1.51 |
09:45 ET | 4822 | 1.51 |
09:48 ET | 252 | 1.52 |
09:50 ET | 5909 | 1.53 |
09:52 ET | 4708 | 1.54 |
09:54 ET | 442 | 1.54 |
09:56 ET | 1749 | 1.54 |
09:57 ET | 5100 | 1.535 |
09:59 ET | 200 | 1.54 |
10:01 ET | 200 | 1.54 |
10:03 ET | 1052 | 1.54 |
10:06 ET | 200 | 1.54 |
10:08 ET | 3195 | 1.54 |
10:10 ET | 200 | 1.54 |
10:12 ET | 500 | 1.54 |
10:14 ET | 2225 | 1.54 |
10:15 ET | 100 | 1.535 |
10:17 ET | 600 | 1.54 |
10:19 ET | 500 | 1.54 |
10:21 ET | 300 | 1.54 |
10:24 ET | 300 | 1.535 |
10:26 ET | 7634 | 1.545 |
10:28 ET | 6786 | 1.54 |
10:30 ET | 5770 | 1.55 |
10:32 ET | 2159 | 1.546 |
10:33 ET | 4448 | 1.56 |
10:35 ET | 400 | 1.56 |
10:37 ET | 700 | 1.56 |
10:39 ET | 400 | 1.555 |
10:42 ET | 200 | 1.56 |
10:44 ET | 1400 | 1.56 |
10:46 ET | 400 | 1.56 |
10:48 ET | 2563 | 1.56 |
10:50 ET | 2412 | 1.565 |
10:51 ET | 6199 | 1.57 |
10:53 ET | 500 | 1.57 |
10:55 ET | 1009 | 1.58 |
10:57 ET | 700 | 1.575 |
11:00 ET | 5876 | 1.57 |
11:02 ET | 9701 | 1.565 |
11:04 ET | 1500 | 1.565 |
11:06 ET | 495 | 1.565 |
11:08 ET | 940 | 1.565 |
11:09 ET | 5200 | 1.565 |
11:11 ET | 1254 | 1.565 |
11:13 ET | 18533 | 1.575 |
11:15 ET | 1900 | 1.58 |
11:18 ET | 418 | 1.58 |
11:20 ET | 6925 | 1.59 |
11:22 ET | 7695 | 1.59 |
11:24 ET | 11653 | 1.605 |
11:26 ET | 2715 | 1.61 |
11:27 ET | 1052 | 1.61 |
11:29 ET | 14848 | 1.615 |
11:31 ET | 12252 | 1.63 |
11:33 ET | 3000 | 1.63 |
11:36 ET | 1900 | 1.63 |
11:38 ET | 649 | 1.63 |
11:40 ET | 849 | 1.63 |
11:42 ET | 851 | 1.63 |
11:44 ET | 1200 | 1.63 |
11:45 ET | 11269 | 1.62 |
11:47 ET | 100 | 1.62 |
11:49 ET | 6774 | 1.61 |
11:54 ET | 6252 | 1.62 |
11:56 ET | 100 | 1.62 |
11:58 ET | 600 | 1.62 |
12:00 ET | 400 | 1.62 |
12:02 ET | 100 | 1.62 |
12:03 ET | 3400 | 1.615 |
12:05 ET | 300 | 1.615 |
12:07 ET | 4909 | 1.62 |
12:09 ET | 400 | 1.62 |
12:12 ET | 500 | 1.62 |
12:14 ET | 367 | 1.61 |
12:16 ET | 600 | 1.615 |
12:18 ET | 3781 | 1.62 |
12:20 ET | 1200 | 1.62 |
12:21 ET | 4149 | 1.615 |
12:23 ET | 900 | 1.62 |
12:25 ET | 1851 | 1.62 |
12:27 ET | 200 | 1.62 |
12:30 ET | 9773 | 1.615 |
12:32 ET | 300 | 1.615 |
12:34 ET | 1559 | 1.615 |
12:36 ET | 947 | 1.615 |
12:38 ET | 457 | 1.62 |
12:39 ET | 200 | 1.62 |
12:41 ET | 1643 | 1.62 |
12:43 ET | 2715 | 1.62 |
12:45 ET | 2927 | 1.615 |
12:48 ET | 300 | 1.62 |
12:50 ET | 1794 | 1.615 |
12:52 ET | 518 | 1.62 |
12:54 ET | 300 | 1.615 |
12:56 ET | 1461 | 1.615 |
12:57 ET | 1721 | 1.615 |
12:59 ET | 400 | 1.62 |
01:01 ET | 300 | 1.615 |
01:03 ET | 13556 | 1.595 |
01:06 ET | 100 | 1.595 |
01:08 ET | 1170 | 1.595 |
01:10 ET | 944 | 1.595 |
01:12 ET | 600 | 1.595 |
01:14 ET | 500 | 1.595 |
01:15 ET | 700 | 1.595 |
01:19 ET | 310 | 1.59 |
01:21 ET | 1105 | 1.595 |
01:24 ET | 200 | 1.6 |
01:26 ET | 300 | 1.595 |
01:28 ET | 1570 | 1.595 |
01:30 ET | 500 | 1.595 |
01:32 ET | 700 | 1.595 |
01:33 ET | 500 | 1.6 |
01:35 ET | 300 | 1.595 |
01:37 ET | 200 | 1.59 |
01:39 ET | 582 | 1.6 |
01:42 ET | 4989 | 1.595 |
01:44 ET | 1054 | 1.595 |
01:46 ET | 630 | 1.595 |
01:48 ET | 11906 | 1.58 |
01:50 ET | 4417 | 1.58 |
01:51 ET | 18418 | 1.575 |
01:53 ET | 2701 | 1.575 |
01:55 ET | 400 | 1.57 |
01:57 ET | 3639 | 1.58 |
02:00 ET | 355 | 1.58 |
02:02 ET | 2200 | 1.58 |
02:04 ET | 1420 | 1.57 |
02:06 ET | 344 | 1.58 |
02:08 ET | 500 | 1.575 |
02:09 ET | 1320 | 1.575 |
02:11 ET | 541 | 1.57 |
02:13 ET | 2378 | 1.58 |
02:15 ET | 310 | 1.57 |
02:18 ET | 937 | 1.58 |
02:20 ET | 8514 | 1.575 |
02:22 ET | 2429 | 1.575 |
02:24 ET | 1772 | 1.57 |
02:26 ET | 2197 | 1.575 |
02:27 ET | 2050 | 1.575 |
02:29 ET | 312 | 1.58 |
02:31 ET | 12470 | 1.55 |
02:33 ET | 6588 | 1.54 |
02:36 ET | 2279 | 1.54 |
02:38 ET | 1287 | 1.545 |
02:40 ET | 917 | 1.545 |
02:42 ET | 410 | 1.54 |
02:44 ET | 452 | 1.54 |
02:45 ET | 1071 | 1.54 |
02:47 ET | 4500 | 1.54 |
02:49 ET | 10348 | 1.545 |
02:51 ET | 5090 | 1.54 |
02:54 ET | 1600 | 1.545 |
02:56 ET | 18379 | 1.55 |
02:58 ET | 200 | 1.55 |
03:00 ET | 623 | 1.545 |
03:02 ET | 800 | 1.55 |
03:03 ET | 642 | 1.55 |
03:05 ET | 500 | 1.55 |
03:07 ET | 722 | 1.55 |
03:09 ET | 1135 | 1.545 |
03:12 ET | 728 | 1.545 |
03:14 ET | 5761 | 1.545 |
03:16 ET | 1987 | 1.545 |
03:18 ET | 1510 | 1.55 |
03:20 ET | 1554 | 1.545 |
03:21 ET | 47902 | 1.57 |
03:23 ET | 508 | 1.57 |
03:25 ET | 936 | 1.57 |
03:27 ET | 1512 | 1.57 |
03:30 ET | 1011 | 1.565 |
03:32 ET | 956 | 1.57 |
03:34 ET | 826 | 1.56 |
03:36 ET | 1667 | 1.56 |
03:38 ET | 756 | 1.57 |
03:39 ET | 5593 | 1.565 |
03:41 ET | 1471 | 1.565 |
03:43 ET | 1004 | 1.56 |
03:45 ET | 4558 | 1.56 |
03:48 ET | 900 | 1.565 |
03:50 ET | 2541 | 1.57 |
03:52 ET | 13304 | 1.55 |
03:54 ET | 1100 | 1.55 |
03:56 ET | 5275 | 1.56 |
03:57 ET | 3802 | 1.55 |
03:59 ET | 11861 | 1.56 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adicet Bio Inc | 122.4M | -0.5x | --- |
Citius Pharmaceuticals Inc | 119.2M | -2.7x | --- |
Allakos Inc | 125.7M | -0.6x | --- |
aTyr Pharma Inc | 124.2M | -2.0x | --- |
Corvus Pharmaceuticals Inc | 128.9M | -4.0x | --- |
Nuvectis Pharma Inc | 114.0M | -4.7x | --- |
Adicet Bio, Inc. is a clinical stage biotechnology company. The Company is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma (NHL). Its pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications. Its pipeline has several additional internal gamma delta T cell therapy programs in discovery and preclinical development for both hematological malignancies and solid tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $122.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 82.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.95 |
EPS | $-2.95 |
Book Value | $3.93 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.